The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / EULAR 2015: Benefits of Individualizing Exercise Therapy

EULAR 2015: Benefits of Individualizing Exercise Therapy

September 15, 2015 • By Rikke Helene Moe, PT, MSc, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Individualized exercise improves RMD symptoms without negative impact to organs.

Individualized exercise improves RMD symptoms
without negative impact to organs.
Image Credit: Photographee.eu/shutterstock.com

ROME, Italy—The medical environment is increasingly adapting to the possibilities of optimizing care by individualizing medical treatment and tailoring treatment to disease phenotypes. Data suggest that individualizing exercise therapy, an important treatment modality for rheumatic and musculoskeletal diseases, can help control disease, maximize function, minimize functional barriers and decrease the risk of co-morbidity.1,2,3

You Might Also Like
  • EULAR 2015: Innovations in Rheumatology Education, Practice
  • EULAR 2015: Cardiovascular Concerns, Infertility in RA
  • EULAR 2015: Imaging in Rheumatology
Explore This Issue
September 2015

Personalizing exercise interventions implies each patient is physically assessed and that exercise interventions are adjusted to address individual deficits and designed based on current knowledge about rheumatic and musculoskeletal disease (RMD) phenotypes, functioning, co-morbidity, accessibility and current knowledge regarding exercise intensity and progression for the specific phenotype. For example, individuals who have a low sensitivity to their exercise program may need to increase intensity or vary activity to achieve the intended response. Others who experience severe RMD with significant involvement of inner organs may need close monitoring and frequent adjustments of exercises.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Exercise therapy is generally recommended as a primary component of RMD management;1 however, there are indications that the intensity of exercise therapy has been suboptimal.2 In general terms, the American College of Sports Medicine recommendations for the prescription of exercise apply to people with RMDs; however, individual and disease-specific adjustments are needed.3

What’s Appropriate?

At EULAR 2015, the annual congress of the European League Against Rheumatism (EULAR), a team of international experts synthesized the data on the beneficial effects of exercise for different RMDs. Specifically, the session focused on appropriate intensity levels of exercise in RMDs, how to measure intensity, barriers and facilitators for applying optimal exercise intensity, and potential adverse effects of exercise.4

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Research demonstrates individualized exercise improves RMD symptoms without negative impact to organs and improves cardiovascular health and disease activity in inflammatory diseases, such as rheumatoid arthritis, spondyloarthropathies and myositis.5-9

Based on the knowledge of an increased risk of cardiovascular disease in certain RMDs, Hanne Solveig Dagfinrud, PT, PhD, emphasized that exercise prescriptions to manage RMDs have become increasingly important. Exercise programs should aim to improve cardiovascular fitness and reduce cardiovascular risk factors. The level of intensity of cardiorespiratory fitness and muscle strength should be individually assessed and exercise should be tailored accordingly.

Several simple clinical tests can be used to determine the level of strength, balance and aerobic capacity of each individual to optimally tailor exercise to each person. A heart rate monitor and/or a scale for personal rating of exertion (i.e., Borg Scale) may be used to control the intensity level.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: exercise therapy, patient care, RA, rheumatic and musculoskeletal disease phenotypes, Rheumatoid arthritis, RMD, TreatmentIssue: September 2015

You Might Also Like:
  • EULAR 2015: Innovations in Rheumatology Education, Practice
  • EULAR 2015: Cardiovascular Concerns, Infertility in RA
  • EULAR 2015: Imaging in Rheumatology
  • Physical Activity, Exercise Can Benefit Patients with RA

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)